Delivery Order SPE2DX15D3020-SPE2DX24FXHPG
Award Date
10/24/23
Potential Completion Date
10/25/23
Potential Value
$34K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,141.20, is for the delivery of Olmesartan-HCTZ 40-25 mg tablets in quantities of 30. It is a Firm Fixed Price Delivery Order contract with a completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.67 delivery order contract covers the supply of Olmesartan-HCTZ 20-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of November 22, 2024 and uses a firm fixed price pricing type. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,545.60, is a delivery order for the supply of Olmesartan-HCTZ 40-12.5 mg tablets. The contract has an ultimate completion date of July 25, 2024 and utilizes a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract provides for the delivery of 4,563,155,110 units of Olmesartan Medoxomil 40 mg tablets in 90-count bottles, with a ceiling value of $5,059.29 and a completion date of December 21, 2023. The award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Olmesartan Medoxomil 40 mg tablets. The contract, valued at $3,391.38, is a firm fixed-price delivery order with a period of performance ending on September 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $3,059.59 and is a delivery order with a firm fixed price. The contract covers the supply of Olmesartan Medoxomil 40 mg tablets in 30-count packages to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Olmesartan-HCTZ 40-25 mg tablets to support federal healthcare programs. The $1,919.59 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary contracting agency for this contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,711.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is for the supply of Olmesartan Medoxomil 40 mg tablets. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,567.90 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of July 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, provides for the delivery of Olmesartan-HCTZ 40-25 mg tablets to the U.S. government. The $1,728.94 firm-fixed price Delivery Order contract, placed under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, supports the agency's mission to provide logistics, acquisition, and technical services to...